Pharmacokinetic evaluation of fluconazole in critically ill patients

Author： Sinnollareddy Mahipal   Peake Sandra L   Roberts Michael S   Playford E Geoffrey   Lipman Jeffrey   Roberts Jason A  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.11, 2011-11, pp. : 1431-1440

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Evaluation of Meropenem and Imipenem in Critically Ill Patients with Sepsis

By Novelli Andrea  

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 539-549

Adis International

Access to resources Recommend Favorite

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.  

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Antimicrobial Therapy in Critically Ill Patients: A Review of Pathophysiological Conditions Responsible for Altered Disposition and Pharmacokinetic Variability

By Pea Federico  

Clinical Pharmacokinetics, Vol. 44, Iss. 10, 2005-01 ,pp. : 1009-1034

Adis International

Access to resources Recommend Favorite

Normoglycaemia benefits critically ill patients

By  

Inpharma, Vol. 1, Iss. 1314, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Consider possible changes in the pharmacokinetic properties of antibacterials when treating the critically ill

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 9, 2006-09 ,pp. : 21-23

Adis International

Access to resources Recommend Favorite